- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
ACL Market Currents
more »
-
June 21, 2011 Maxim Group initiates Affymetrix (AFFX +8.3%) with a buy, saying the company is well positioned to benefit from improved demand for microarrays in the second half of the year. It has a string of new products, and a new distribution agreement with Thermo Fisher (TMO +2%).
Comment![Healthcare]
ACL in Focus
more »
ACL Related Articles
more »
ACL News
more »
-
at CNBC.com (Dec 16, 2010)
-
at MarketWatch.com (Dec 16, 2010)
-
at MarketWatch.com (Dec 15, 2010)
-
at MarketWatch.com (Dec 15, 2010)
-
at CNBC.com (Dec 15, 2010)
ACL Press Releases and Filings
more »
Currently, there are no press releases or filings on ACL.
ACL Latest Transcript
more »
ACL Cramer
more »
-
Tue, Nov 10, 2009
-
Tue, Feb 24, 2009
-
Thu, Oct 11, 2007
ACL Instablog posts
more »
ACL vs. ETF Alternatives
Company Description
Founded in 1945, Alcon Laboratories, Inc. traces its roots back to two pharmacists, Robert Alexander and William Conner, who opened a small pharmacy in Fort Worth, Texas, and combined the first syllables of their last names to create the name Alcon.
Majority owned by Nestlé S.A. and... More